Nikko Asset Management Americas, Inc. just provided an update on share ownership of CRISPR Therapeutics AG

Nikko Asset Management Americas, Inc. just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though Nikko Asset Management Americas, Inc. claims to own 3,836,823 shares. This represents 5.39% of CRISPR Therapeutics AG.

Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.

To receive a free e-mail notification whenever CRISPR Therapeutics AG makes a similar move, sign up!

Other recent filings from the company include the following:

CRISPR Therapeutics AG's Chief Executive Officer just cashed-in 30,000 options - June 17, 2021
CRISPR Therapeutics AG director just disposed of 10,000 shares - June 15, 2021
CRISPR Therapeutics AG director was just granted 10,000 options - June 14, 2021
Amendments to Articles of Incorporation or - June 14, 2021
Statement of changes in beneficial ownership of securities - June 14, 2021

Auto Refresh

Feedback